In high-grade plasmacytoid ovarian cancer, the tumor microenvironment suppresses PSAP expression during progression, reducing secretion of anti-tumor protein thrombospondin-1 (TSP-1) and enabling immune evasion. The gene discussed is PSAP; the disease is neoplasm.